Phase 3 N=49 Use of Ultrase® MT12 in Young Cystic Fibrosis Children (CF)
Cystic Fibrosis · Pancreatic Insufficiency
Primary: Percentage of Patients With Control of Steatorrhea — 46.9; 42.9 percentage of patients
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=120 Trial Comparing hCG Triggering Versus hCG Associated With GnRH Agonist
Infertility
Primary: MII Oocytes — 9.2; 10.3 cumulus oocyte complex
Phase 3 N=204 Study of Lanreotide Autogel in Non-functioning Entero-pancreatic Endocrine Tumours
Endocrine Tumors
Primary: Progression-Free Survival (PFS) — NA; 72 Weeks — p=<0.001
Phase 3 N=119 Reducing Dynamic Hyperinflation Through Breathing Retraining
Pulmonary Disease · COPD
Primary: Exercise Duration (Time Walked on the Constant Workrate Treadmill Test) — 15.2; 17.6 minutes — p=0.63
Early Phase 1 N=33 Supported Education Pilot
PTSD
Primary: "Supported Education Process Measure" — 26.2; 8.2 number of quarter hours — p=0.0059
Phase 2 N=15 Phase II Efficacy Study Looking at a Single-dose of One of Three Dose Levels of AIN457 in Patients With Chronic Plaque-type Psoriasis
Chronic Plaque Psoriasis
Primary: Change From Baseline in Psoriasis Area and Severity Index (PASI) Scores
N/A N=30 Estrogen Sensitivity and Ovulatory Dysfunction in Obesity
Obesity · Infertility
Primary: Luteinizing Hormone Pulse Amplitude — 2.73; 1.12 IU/L
N/A N=89 Fish Oil and Green Tea Extract in Preventing Prostate Cancer in Patients Who Are at Risk for Developing Prostate Cancer
Precancerous Condition · Prostate Cancer
Primary: Fatty Acid Synthase Expression by Immunohistochemistry at Pre- and Post-intervention (FAS Summary Score) — 147; 158.8; 138.3; 102.3 units on a scale — p=0.1521
N/A N=35 Plasma Protein Binding Characteristics of Voriconazole
Focus of the Study:Protein Binding Characteristics of Voriconazole.
Primary: Differences in Overall Protein Binding in the Presence of Different Plasma Albumin Concentrations. — 49.1; 49.6 % of plasma protein binding
Phase 3 N=2,640 Comparison of the Safety of Flublok® Versus Licensed IIV in Healthy, Medically Stable Adults ≥ 50 Years of Age
Influenza
Primary: Number of Participants With Common Hypersensitivity Reactions as Measure of Safety — 31; 21 participants
N/A N=81 Optimizing Vitamin D in the Elderly
Deficiency of Vitamin D3
Primary: Total 25-OH Vitamin D3 Level — 33; 34; 43; 61 ng/mL — p=<.0001
Phase 2 N=200 Effect of Paracetamol on the Common Cold
Common Cold
Primary: Breathing Scores Post 15 Minutes — 0.83; 0.11 Score on a Scale — p=<0.0001
Phase 2 N=207 Study to Evaluate the Efficacy and Safety of Intravenous Infusion With Nemonoxacin Malate Sodium Chloride
Pneumonia
Primary: Difference in the Clinical Cure Rate of Two Doses of Intravenously Infused Nemonoxacin Malate Sodium Chloride Injection at Visit 4 in the mITT Population — 60; 58; 59; 7…
Phase 3 N=50 An Open-label Trial of Clevidipine for Controlled Hypotension During Spinal Fusion
Neuromuscular Scoliosis
Primary: Time to Achieve Target MAP — 9.2 minutes
Phase 3 N=764 Prevention of Relapse With Injectable Paliperidone Palmitate Versus Oral Antipsychotics
Schizophrenia
Primary: Time to First Relapse Event — 616; 603 days — p=0.0191